- Home
- TCBK vs TRML Comparison
TCBK vs TRML Comparison
Compare TCBK & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBK
- TRML
- Stock Information
- Founded
- TCBK 1975
- TRML 2021
- Country
- TCBK United States
- TRML United States
- Employees
- TCBK N/A
- TRML N/A
- Industry
- TCBK Major Banks
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- TCBK Finance
- TRML Health Care
- Exchange
- TCBK Nasdaq
- TRML Nasdaq
- Market Cap
- TCBK 1.4B
- TRML 1.2B
- IPO Year
- TCBK N/A
- TRML N/A
- Fundamental
- Price
- TCBK $43.58
- TRML $47.89
- Analyst Decision
- TCBK Buy
- TRML Hold
- Analyst Count
- TCBK 5
- TRML 12
- Target Price
- TCBK $47.60
- TRML $47.04
- AVG Volume (30 Days)
- TCBK 93.1K
- TRML 820.8K
- Earning Date
- TCBK 10-23-2025
- TRML 11-06-2025
- Dividend Yield
- TCBK 3.03%
- TRML N/A
- EPS Growth
- TCBK N/A
- TRML N/A
- EPS
- TCBK 3.39
- TRML N/A
- Revenue
- TCBK $391,277,000.00
- TRML N/A
- Revenue This Year
- TCBK $9.45
- TRML N/A
- Revenue Next Year
- TCBK $5.81
- TRML N/A
- P/E Ratio
- TCBK $12.86
- TRML N/A
- Revenue Growth
- TCBK 0.78
- TRML N/A
- 52 Week Low
- TCBK $35.20
- TRML $11.56
- 52 Week High
- TCBK $51.06
- TRML $48.27
- Technical
- Relative Strength Index (RSI)
- TCBK 45.53
- TRML 91.34
- Support Level
- TCBK $43.31
- TRML $47.83
- Resistance Level
- TCBK $44.97
- TRML $47.94
- Average True Range (ATR)
- TCBK 0.73
- TRML 0.10
- MACD
- TCBK -0.22
- TRML -0.73
- Stochastic Oscillator
- TCBK 13.13
- TRML 39.66
About TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.